Prev Close | 162.85 |
Open | 162.29 |
Day Low/High | 156.93 / 164.07 |
52 Wk Low/High | 155.11 / 218.18 |
Volume | 1.40M |
Prev Close | 162.85 |
Open | 162.29 |
Day Low/High | 156.93 / 164.07 |
52 Wk Low/High | 155.11 / 218.18 |
Volume | 1.40M |
Exchange | NASDAQ |
Shares Outstanding | 104.78B |
Market Cap | 18.75B |
P/E Ratio | 31.43 |
Div & Yield | N.A. (N.A) |
Upside - +328% (to be acquired by Regeneron at $10.50/shr in $250M all-cash deal) - +29% (granted Fast Track Designation for AR101 to treat vascular Ehlers-Danlos syndrome) - +27% (disclosed received and agreed to Postmarketing Requirements/Commitme...
Place a percentage on the likelihood of recession? It sounds more like someone trying harder to not get it wrong than trying to get it right.
Few things are sweeter than buying into unjustly beaten-up shares right before they begin major rebounds.
Then why not apply the same logic to stocks. Trucking firm J.B. Hunt is a true 'left to right' growth, modestly undervalued name.
The SPDR S&P Biotech ETF is one for traders to keep on their radar.
Investors were aggressively selling the stock of any company that moves freight. Not typically a good sign.
Here's why this stock is one of my top picks for the remainder of 2022, despite the chaos surrounding fuel costs.
Berkshire, led by the brilliant pair of Warren Buffett and Charlie Munger, has been busy of late.
While professional money likely participated heavily on Wednesday, the percentage of these trades that were simply price insensitive, short interest covering, risk removal trades may have been substantial.
Once considered boring, supply chains and logistics has become one of the most talked-about sectors in the market.
The company is set to report earnings after the close Tuesday.
In short, Friday was simply an absolute disaster for the U.S. in macroeconomic terms.
I have had some real success playing volatile names ahead of news events from the short-side, but this is not something I would recommend for newer traders.
Here's why fears of a Dow Theory nonconfirmation signal are over blown.
Plus, an FDA advisory panel gives a unanimous boost to a Moderna booster shot and Boeing slumps on a negative news report.
These guys are aware that the U.S. was energy independent less than a year and a half ago, right?
There's no way to disguise investor sentiment when, for the week, the four defensive sectors easily take the top four slots.
Let's look at the companies that can go up, and the ones that can't.
How Interesting. On Wednesday, market participants rotated out of the un-rotation that had been in vogue for most of April.
Plus, we check in on Peloton and Datadog and the Nasdaq Composite Index.
Markets have certainly recovered nicely off of the lows of late September. Now, here in mid-October, it feels like it did that cold night back in 1980-something. The wolves are visible and noisy.
Next week the June quarter earnings season maelstrom kicks off with 115 companies, including 32 S&P 500 constituents, reporting their latest quarterly results. In recent days we've seen a number of companies up their outlook for the quarter but we'v...
Let's check the GPS and come up with a trading strategy.
Equity markets had a tougher day on Wednesday than immediately meets the eye. And did you catch what Trump said?